Connect with us

International

5 Largest Uranium Producers in the World

Following a year that saw uranium rank among the best performing commodities, 2021 has seen the value of the energy fuel continue to rise.Uranium started the year at US$29.63 and prices have trended higher over the last 11 months, pushing the nuclear…

Published

on



Following a year that saw uranium rank among the best performing commodities, 2021 has seen the value of the energy fuel continue to rise.

Uranium started the year at US$29.63 and prices have trended higher over the last 11 months, pushing the nuclear fuel to a nine year high in September when prices hit an intraday high of US$50.76.

Production declines from 2020 closures aided in the price growth. However, a widespread push towards nuclear as a clean energy source has served as a primary catalyst to the value increase.


U3O8 prices saw their largest quarterly gain in Q3, rising 56 percent from the beginning of the period to the September high. Much of the Q3 positivity was the result of the Sprott Physical Uranium Trust (TSX:U.UN), which officially launched on July 19.

Created out of the acquisition of Uranium Participation, a Toronto-based holding company investing nearly all of its assets in uranium, the Sprott trust began to quickly make waves in the nuclear fuel sector.

By mid-September, Sprott's uranium holdings ballooned to more than 27.7 million pounds worth US$1.46 billion.

As the trust bought up pounds on the tightening spot market, attention was drawn to the growing discrepancy between rising demand and the current low production level.

There is also competition on the spot market from producers who are purchasing to meet contracts, following a year of mine shutdowns and logistic woes.

Supply issues rising from purchases by Sprott and other producers will be further compounded by increased demand from the nuclear fuel sector.

Even though some nuclear projects were delayed in 2020, the future of the sector holds promise as countries strive to meet ambitious emissions and pollution-reduction targets.

New nuclear reactors will require more uranium production, which bodes well for uranium-producing companies. The long-term outlook for uranium shows that demand is projected to climb 25 percent higher by 2025. This uptick will largely come from Asia's robust and growing nuclear energy industry.

There is also increasing interest in small modular reactors. Capitalizing on the same processes used to create nuclear power on a smaller scale, small modular reactors offer an additional way to integrate atomic energy into a project or energy grid.

With that in mind, it's worth looking at which companies are the world's leading uranium miners. The list below lays out 2020's five largest uranium companies that are publicly traded, providing a brief overview of what they got up to last year and what news they have released so far in 2021.

1. BHP (NYSE:BHP,ASX:BHP,LSE:BHP)


2020 production: 8.1 million pounds uranium oxide concentrate

Major miner BHP's Olympic Dam mine in Australia is one of the largest uranium deposits in the world. Although copper is the primary resource mined at Olympic Dam, the project also hosts uranium, gold and silver. According to the company, Olympic Dam has a fully integrated processing facility.

After completing a comprehensive study, the company decided to scrap plans for a brownfield expansion at Olympic Dam in late 2020.

Citing the complexity of the copper deposit, BHP instead has opted to focus on "targeted debottlenecking investments, plant upgrades and modernisation of our infrastructure" at the Australian property.

In 2020, output from the uranium project increased .8 percent year-over-year. Totals climbed from 7.8 million pounds of uranium oxide concentrate to 8.1 million pounds.

The Australian mine also houses a massive uranium reserve. According to the World Nuclear Association, Olympic Dam has an estimated 347,000 tonnes of contained uranium oxide.

Currently, BHP is looking for new opportunities to add to its resource profile. One such property is Oak Dam in South Australia. In 2020, BHP conducted additional drilling at the site. The results are under review, but previous results indicate high-grade copper, gold, silver and uranium mineralization.

2. Cameco (TSX:CCO,NYSE:CCJ)


2020 production: 5 million pounds uranium

In 2019, Cameco topped the list of publicly traded uranium producers, accounting for 9 percent of the world's uranium production. In 2020, the uranium major's output instead made up 6 percent of global demand.

The 4 million pound decline in production in 2020 was the result of project shutdowns in Canada, a segment that factors largely in the company's annual tallies.

Cameco's notable Canadian operations include Cigar Lake, which is considered the most prolific uranium mine in the world. Cameco's Canadian operations also operates the McArthur River mine and Key Lake mill, located in the Athabasca Basin, a well-known uranium jurisdiction.

In the US, Cameco owns the Smith Ranch-Highland operation in Wyoming's Powder River Basin, as well as the Crow Butte operation in Nebraska.

Additionally, Cameco has a 60 percent stake in a mine in Kazakhstan.

Due to COVID-19 regulations, Cameco temporarily suspended production at Cigar Lake in early 2020. Operations at the mine were curtailed until late September which is reflected in the annual output.

Despite the losses of 2020, the uranium miner remains optimistic regarding the future of the nuclear fuel sector. The company also sees a growing opportunity in the widespread electrification happening around the globe.

"Demand for nuclear power is growing and not just the traditional uses of nuclear power. There is a real focus on, and significant investments being made in the development of non-traditional uses, like small modular reactors," Tim Gitzel, Cameco's president and CEO, said in a quarterly review.

The CEO noted that all these factors and the growing demand they raise will undoubtedly face supply challenges.

"On the supply side there are some big question marks about where uranium will come from to fuel the world's growing demand for nuclear power due to years of persistently low prices that have led to planned production curtailments, lack of investment, the end of reserve life for some mines, shrinking secondary supplies and trade policy issues, which are currently being amplified by unplanned disruptions due to the COVID-19 pandemic," he said.

In 2018, the world's leading uranium producer shuttered McArthur River and Key Lake due to weak spot prices. The closure of the property reduced Cameco's uranium supply dramatically from 23.8 million pounds in 2017 to 9.2 million pounds in 2018, down 61 percent.

3.  Energy Resources of Australia (ASX:ERA)


2020 production: 3.47 million pounds uranium oxide

Energy Resources of Australia (ERA) operates the Australia-based Ranger mine, the continent's longest running uranium mine. While mining stopped at Ranger in 2012, the company is currently still producing material from stockpiled uranium ore.

2020 was the final full year of production for Ranger as the mine was officially decommissioned in January 2021. The Australian mine will now go through final rehabilitation, which is slated to conclude by January 2026.

Production from Ranger's last year totaled 3.47 million pounds, a slight year over year decline from 2019's 3.8 million pounds of uranium. Although output dropped, overall production fell in line with yearly guidance.

"ERA will continue to sell contracted and uncontracted drummed uranium oxide to Rio Tinto Uranium for on sale to a variety of customers," the 2020 annual report read.

Energy Resources is continuing rehabilitation of the Ranger project site and is working towards finalizing closure.

4. Rio Tinto (NYSE:RIO,ASX:RIO,LSE:RIO)


2020 production: 2.8 million pounds uranium

Rio Tinto slipped from the third spot to number four on the list of largest uranium producers in 2020. Uranium output from the mining major fell 40 percent year-over-year, from 4.7 million pounds in 2019 to 2.8 million pounds in 2020.

This marks the second year of significant declines for the international miner. In 2019, output fell 29 percent year-over-year, slipping from 6.7 million pounds in 2018 to 4.7 million pounds.

Rio Tinto's uranium output comes partially through the 68.4 percent stake it holds in Energy Resources of Australia, which manages the Ranger mine, Australia's longest continually operating producer of uranium.

Rio attributes part of the output reduction to the lower-grade ore being processed at Ranger.

While the Ranger mine contributed 2 percent of the world's uranium in 2018, it did not make the World Nuclear Association's list of top-producing mines in 2019.

Prior to November 2018, Rio Tinto held a stake in the Rossing uranium mine in Namibia, one of the world's largest and longest-running open-pit uranium mines. Rio sold its stake in the African project to China National Uranium for an estimated US$106 million.

The full divestment was completed in July 2020.

5. Other uranium-producing companies


Two of the largest global uranium producers straddle the Europe-Asia border: Kazatomprom and Uranium One. Kazatomprom, the private national uranium and nuclear energy company of Kazakhstan, has several operations and joint ventures globally. As the largest uranium producer in 2019, its output topped 23.6 million pounds, or 22 percent of global supply.

Uranium One is a private subsidiary of Rosatom, Russia's state-owned nuclear company. In 2020, Uranium One accounted for 9 percent of world output.

Orano, formerly AREVA, was a publicly traded company until 2017, when it was "split in two and recapitalized … after years of losses wiped out its equity." It is also a significant uranium producer. Since the separation, Orano has done well, and contributed 9 percent of global uranium supply in 2020.

Aside from the largest uranium producers listed above, there are of course companies that produced smaller amounts. These smaller players include Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU), which put out 196,500 pounds of U3O8, and Ur-Energy (TSX:URE,NYSEAMERICAN:URG), whose 2019 U3O8 output came in at 10,789 pounds.

Don't forget to follow us @INN_Resource for real-time updates!

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Energy Fuels is a client of the Investing News Network. This article is not paid-for content.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending